Fulgent Genetics, Inc. FLGT Notes Payable
Notes Payable at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NotesPayableCurrent.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s notes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s notes payable?
- Fulgent Genetics, Inc. (FLGT) reported notes payable of $482K in Q1 2026.
- How has Fulgent Genetics, Inc.'s notes payable changed year-over-year?
- Fulgent Genetics, Inc.'s notes payable increased by 1.3% year-over-year, from $476K to $482K.
- What is the long-term trend for Fulgent Genetics, Inc.'s notes payable?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s notes payable has grown at a -47.2% compound annual growth rate (CAGR), from $6.15M to $476K.
- What does notes payable mean?
- This represents formal written promises to pay specific sums of money to creditors at a future date, typically involving interest obligations. It serves as a component of the company's short-term or long-term debt structure used to finance operations or capital expenditures. Monitoring this metric is essential for assessing the company's leverage and its ability to meet contractual debt obligations.